Latest news from the EMCDDA

European Drug Report 2020

09.06.2021 - the EMCDDA publishes its European Drug Report 2021, the latest annual review of the drug situation in Europe. The report offers new insights into the health and security implications of a complex and evolving drugs problem and of a drug market resilient to COVID-19 disruption.

spacer3.jpg

Hepatitis C in Europe

07.2021 - EMCDDA Elimination barometer and its Manual about hepatitis C.

Drugs and prison in Europe

06.2021 - Current insights and future challenges on drugs and prison in a new EMCDDA study.

 

 

 

 

 

 

 

 

 

Quick access to the EMCDDA main publications archives

 Databases


minilogoOFDT.jpg

The OFDT provides an online bibliographic database on addiction.

 
Books3.jpg

The EMCDDA provides a database on their publications of interest.

 

 

 

 

 

 

 

 

Drugs in Europe


2021 EMCDDA European Drug Report

COVID-19
How is the COVID-19 pandemic affecting drug use, supply and services?
Drug use and harms
What are the health costs of drug use in Europe today?
Drug markets
What do the latest data tell us about drug production and trafficking trends?

These and other questions are explored in the 2021 European Drug Report, our annual overview of the drug situation in Europe.

  Statistical Bulletin 2021

The annual Statistical Bulletin contains the most recent available data on the drug situation in Europe provided by the Member States. These datasets underpin the analysis presented in the European Drug Report. All data may be viewed interactively on screen and downloaded in Excel format..

The European Union and the drug phenomenon

miniFAQDrugsEurope.jpgThe European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.